[1]CurrentPatentAssignee:AZATRIUSPHARMACEUTICALSPRIVATE-WO2003/95447,2003,A1Locationinpatent:Page/Pagecolumn15-16
[1]Li,Xu-Qin;Wang,Lin;Lei,Yan;Hu,Tao;Zhang,Fei-Long;Cho,Chi-Hin;To,KennethK.W.[EuropeanJournalofMedicinalChemistry,2015,vol.101,p.560-572]
[2]CurrentPatentAssignee:IZUMITECHNOLOGYLLC-US2019/343827,2019,A1Locationinpatent:Paragraph0316-1317
[1]Li,Xu-Qin;Wang,Lin;Lei,Yan;Hu,Tao;Zhang,Fei-Long;Cho,Chi-Hin;To,KennethK.W.[EuropeanJournalofMedicinalChemistry,2015,vol.101,p.560-572]
[1]Li,Xu-Qin;Wang,Lin;Lei,Yan;Hu,Tao;Zhang,Fei-Long;Cho,Chi-Hin;To,KennethK.W.[EuropeanJournalofMedicinalChemistry,2015,vol.101,p.560-572]
Title: P-Glycoprotein on Blood-Brain Barrier Plays a Vital Role in Fentanyl Brain Exposure and Respiratory Toxicity in Rats.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20180701
Title: Increasing nerve agent treatment efficacy by P-glycoprotein inhibition.
Journal: Chemico-biological interactions 20161125
Title: Inhibition of P-glycoprotein Gene Expression and Function Enhances Triptolide-induced Hepatotoxicity in Mice.
Journal: Scientific reports 20150101
Title: Behavioral effects and central nervous system levels of the broadly available κ-agonist hallucinogen salvinorin A are affected by P-glycoprotein modulation in vivo.
Journal: The Journal of pharmacology and experimental therapeutics 20120601
Title: Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein.
Journal: Journal of medicinal chemistry 20120412
Title: [Evaluation of P-glycoprotein mediated in vitro loperamide biliary excretion with sandwich-cultured rat hepatocytes model].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20120401
Title: Alteration in P-glycoprotein functionality affects intrabrain distribution of quinidine more than brain entry-a study in rats subjected to status epilepticus by kainate.
Journal: The AAPS journal 20120301
Title: Pgp-mediated interaction between (R)-[11C]verapamil and tariquidar at the human blood-brain barrier: a comparison with rat data.
Journal: Clinical pharmacology and therapeutics 20120201
Title: A comparative small-animal PET evaluation of [11C]tariquidar, [11C]elacridar and (R)-[11C]verapamil for detection of P-glycoprotein-expressing murine breast cancer.
Journal: European journal of nuclear medicine and molecular imaging 20120101
Title: Genetic knockdown and pharmacological inhibition of parasite multidrug resistance transporters disrupts egg production in Schistosoma mansoni.
Journal: PLoS neglected tropical diseases 20111201
Title: Increasing oxime efficacy by blood-brain barrier modulation.
Journal: Toxicology letters 20110925
Title: Synthesis and structure-activity evaluation of isatin-β-thiosemicarbazones with improved selective activity toward multidrug-resistant cells expressing P-glycoprotein.
Journal: Journal of medicinal chemistry 20110825
Title: Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin.
Journal: Journal of medicinal chemistry 20110728
Title: Solid phase synthesis of tariquidar-related modulators of ABC transporters preferring breast cancer resistance protein (ABCG2).
Journal: Bioorganic & medicinal chemistry letters 20110615
Title: A novel positron emission tomography imaging protocol identifies seizure-induced regional overactivity of P-glycoprotein at the blood-brain barrier.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20110615
Title: The third-generation P-glycoprotein inhibitor tariquidar may overcome bacterial multidrug resistance by increasing intracellular drug concentration.
Journal: The Journal of antimicrobial chemotherapy 20110401
Title: Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
Journal: Bioorganic & medicinal chemistry 20110315
Title: A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20110201
Title: Synthesis and in vivo evaluation of ¹⁸F-fluoroethyl GF120918 and XR9576 as positron emission tomography probes for assessing the function of drug efflux transporters.
Journal: Bioorganic & medicinal chemistry 20110115
Title: Specific inhibitors of the breast cancer resistance protein (BCRP).
Journal: ChemMedChem 20100903
Title: Synthesis and evaluation of [11C]XR9576 to assess the function of drug efflux transporters using PET.
Journal: Annals of nuclear medicine 20100601
Title: Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[(11)C]verapamil PET.
Journal: European journal of nuclear medicine and molecular imaging 20100501
Title: P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-N-desmethyl-loperamide.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20100401
Title: Assessment of regional differences in tariquidar-induced P-glycoprotein modulation at the human blood-brain barrier.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20100301
Title: Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar.
Journal: NeuroImage 20100115
Title: Novel lead for potent inhibitors of breast cancer resistance protein (BCRP).
Journal: Bioorganic & medicinal chemistry letters 20100101
Title: A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)-11C-verapamil and PET.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20091201
Title: Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
Journal: Journal of controlled release : official journal of the Controlled Release Society 20090521
Title: A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20090515
Title: Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators.
Journal: Bioorganic & medicinal chemistry 20090315
Title: Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar.
Journal: Journal of medicinal chemistry 20090226
Title: Functional and energetic characterization of P-gp-mediated doxorubicin transport in rainbow trout (Oncorhynchus mykiss) hepatocytes.
Journal: Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20090101
Title: Influence of the dual ABCB1 and ABCG2 inhibitor tariquidar on the disposition of oral imatinib in mice.
Journal: Journal of experimental & clinical cancer research : CR 20090101
Title: Tariquidar, a selective P-glycoprotein inhibitor, does not potentiate loperamide's opioid brain effects in humans despite full inhibition of lymphocyte P-glycoprotein.
Journal: Anesthesiology 20081201
Title: Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus.
Journal: Epilepsy research 20081101
Title: Tariquidar-induced P-glycoprotein inhibition at the rat blood-brain barrier studied with (R)-11C-verapamil and PET.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20080801
Title: Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice.
Journal: Journal of cancer research and clinical oncology 20080501
Title: Glutamate is critically involved in seizure-induced overexpression of P-glycoprotein in the brain.
Journal: Neuropharmacology 20080501
Title: Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)).
Journal: Biochemical pharmacology 20080315
Title: Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors.
Journal: Bioorganic & medicinal chemistry 20080301
Title: Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives.
Journal: Bioorganic & medicinal chemistry 20080101
Title: Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats.
Journal: The Journal of pharmacology and experimental therapeutics 20070701
Title: In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity on CYP-450 (Part 2).
Journal: Bioorganic & medicinal chemistry 20070601
Title: Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
Journal: Tuberculosis (Edinburgh, Scotland) 20070501
Title: Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
Journal: Epilepsia 20070301
Title: Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.
Journal: Neuropharmacology 20070201
Title: Multidrug-resistance gene 1-type p-glycoprotein (MDR1 p-gp) inhibition by tariquidar impacts on neuroendocrine and behavioral processing of stress.
Journal: Psychoneuroendocrinology 20070101
Title: In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity at CYP-450.
Journal: Bioorganic & medicinal chemistry 20061201
Title: Quantification of serotonin 5-HT1A receptors in monkey brain with [11C](R)-(-)-RWAY.
Journal: Synapse (New York, N.Y.) 20061201
Title: The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity.
Journal: Clinical pharmacology and therapeutics 20060901
Title: Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.
Journal: Current opinion in pharmacology 20060801
Title: Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier.
Journal: The Journal of pharmacology and experimental therapeutics 20060601
Title: Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia.
Journal: Nature neuroscience 20060401
Title: Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats.
Journal: Epilepsia 20060401
Title: Structure-activity relationships of a series of tariquidar analogs as multidrug resistance modulators.
Journal: Bioorganic & medicinal chemistry 20060301
Title: Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma.
Journal: Cancer 20050815
Title: Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel.
Journal: Cancer biology & therapy 20050801
Title: The coupling mechanism of P-glycoprotein involves residue L339 in the sixth membrane spanning segment.
Journal: FEBS letters 20050718
Title: Modulation of drug resistance transporters as a strategy for treating myelodysplastic syndrome.
Journal: Best practice & research. Clinical haematology 20041201
Title: P-glycoprotein retains function when reconstituted into a sphingolipid- and cholesterol-rich environment.
Journal: Journal of lipid research 20041001
Title: Ex vivo reversal of chemoresistance by tariquidar (XR9576).
Journal: Anti-cancer drugs 20041001
Title: Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
Journal: The Journal of biological chemistry 20040924
Title: Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy.
Journal: European journal of cancer (Oxford, England : 1990) 20040301
Title: Pheophorbide a is a specific probe for ABCG2 function and inhibition.
Journal: Cancer research 20040215
Title: Pumping of drugs by P-glycoprotein: a two-step process?
Journal: The Journal of pharmacology and experimental therapeutics 20031201
Title: The histone deacetylase inhibitor FK228 preferentially enhances adenovirus transgene expression in malignant cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20031101
Title: Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030201
Title: In vitro prevention of the emergence of multidrug resistance in a pediatric rhabdomyosarcoma cell line.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20011001
Title: In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
Journal: Cancer research 20010115
Title: Martin C, et al. The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein. Br J Pharmacol, 1999, 128(2), 403-411.
Title: Mistry P, et al. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. Cancer Res, 2001, 61(2), 749-758.
Title: Zimmermann ES, et al. Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration. Antimicrob Agents Chemother. 2015 Nov 30;60(2):946-54.
Title: Kao YH, et al. Regulation of P-glycoprotein expression in brain capillaries in Huntington's disease and its impact on brain availability of antipsychotic agents risperidone and paliperidone. J Cereb Blood Flow Metab. 2016 Aug;36(8):1412-23.
Title: Matzneller P, et al. Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration. Eur J Drug Metab Pharmacokinet. 2018 Apr 3.
